These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8782642)

  • 1. Small, dense low-density lipoprotein particles and coronary heart disease risk: A clear association with uncertain implications.
    Coresh J; Kwiterovich PO
    JAMA; 1996 Sep; 276(11):914-5. PubMed ID: 8782642
    [No Abstract]   [Full Text] [Related]  

  • 2. Triglycerides and small, dense low-density lipoprotein.
    Enas EA
    JAMA; 1998 Dec; 280(23):1990-1. PubMed ID: 9863842
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of n-3 fatty acids on low density lipoprotein subfractions.
    Griffin BA
    Lipids; 2001; 36 Suppl():S91-7. PubMed ID: 11837999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small, dense low-density lipoprotein as a risk factor for coronary heart disease.
    Austin MA
    Int J Clin Lab Res; 1994; 24(4):187-92. PubMed ID: 7894041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
    Rhoads GG; Gulbrandsen CL; Kagan A
    N Engl J Med; 1976 Feb; 294(6):293-8. PubMed ID: 173994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease.
    Hiki M; Shimada K; Ohmura H; Kiyanagi T; Kume A; Sumiyoshi K; Fukao K; Inoue N; Mokuno H; Miyazaki T; Daida H
    J Cardiol; 2009 Feb; 53(1):108-16. PubMed ID: 19167646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid abnormalities and coronary heart disease.
    Grundy SM
    Clin Symp; 1997; 49(4):1-32. PubMed ID: 9444788
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-density lipoprotein density and atherosclerosis. Unraveling the connection.
    Slyper AH
    JAMA; 1994 Jul; 272(4):305-8. PubMed ID: 8028144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies of VLDL metabolism and LDL heterogeneity.
    Demant T; Packard C
    Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Small, dense LDL].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():554-62. PubMed ID: 11351649
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease.
    Biswas S; Ghoshal PK; Mandal SC; Mandal N
    J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein subclass patterns and risk of myocardial infarction.
    Austin MA; Breslow JL; Hennekens CH; Buring JE; Willett WC; Krauss RM
    JAMA; 1988 Oct; 260(13):1917-21. PubMed ID: 3418853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.